| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥212.70B | ¥243.04B | -12.5% |
| Cost of Sales | ¥165.06B | ¥201.96B | -18.3% |
| Gross Profit | ¥47.64B | ¥41.08B | +16.0% |
| SG&A Expenses | ¥39.39B | ¥35.03B | +12.4% |
| Operating Income | ¥8.25B | ¥6.05B | +36.4% |
| Non-operating Income | ¥10.55B | ¥1.55B | +581.4% |
| Non-operating Expenses | ¥2.89B | ¥5.70B | -49.2% |
| Ordinary Income | ¥15.91B | ¥1.90B | +737.9% |
| Profit Before Tax | ¥14.00B | ¥2.02B | +594.6% |
| Income Tax Expense | ¥2.53B | ¥1.40B | +80.3% |
| Net Income | ¥11.47B | ¥613M | +1771.8% |
| Net Income Attributable to Owners | ¥10.89B | ¥318M | +3323.3% |
| Total Comprehensive Income | ¥18.15B | ¥-2.98B | +709.4% |
| Depreciation & Amortization | ¥12.28B | ¥13.60B | -9.7% |
| Interest Expense | ¥1.67B | ¥636M | +162.1% |
| Basic EPS | ¥112.08 | ¥3.28 | +3317.1% |
| Diluted EPS | ¥112.06 | ¥3.27 | +3326.9% |
| Dividend Per Share | ¥55.00 | ¥55.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥290.76B | ¥358.38B | ¥-67.61B |
| Cash and Deposits | ¥44.71B | ¥115.97B | ¥-71.26B |
| Accounts Receivable | ¥96.37B | ¥106.62B | ¥-10.25B |
| Inventories | ¥66.28B | ¥57.70B | +¥8.58B |
| Non-current Assets | ¥574.84B | ¥507.07B | +¥67.77B |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥31.59B | ¥6.31B | +¥25.29B |
| Investing Cash Flow | ¥-88.80B | ¥-33.11B | ¥-55.69B |
| Financing Cash Flow | ¥-16.07B | ¥19.20B | ¥-35.27B |
| Free Cash Flow | ¥-57.20B | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | 5.1% |
| Gross Profit Margin | 22.4% |
| Current Ratio | 165.5% |
| Quick Ratio | 127.8% |
| Debt-to-Equity Ratio | 1.04x |
| Interest Coverage Ratio | 4.95x |
| EBITDA Margin | 9.7% |
| Effective Tax Rate | 18.1% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | -12.5% |
| Operating Income YoY Change | +36.4% |
| Ordinary Income YoY Change | +737.9% |
| Net Income Attributable to Owners YoY Change | -96.5% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 106.20M shares |
| Treasury Stock | 9.06M shares |
| Average Shares Outstanding | 97.13M shares |
| Book Value Per Share | ¥4,366.26 |
| EBITDA | ¥20.53B |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥55.00 |
| Year-End Dividend | ¥55.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| HighPerformanceUrethans | ¥17.04B | ¥-565M |
| MachineryAndMetalProducts | ¥29.77B | ¥1.89B |
| Pharmaceutical | ¥10.48B | ¥-483M |
| PolymersAndChemicals | ¥118.53B | ¥4.18B |
| SpecialtyProducts | ¥29.82B | ¥4.25B |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥490.00B |
| Operating Income Forecast | ¥25.00B |
| Ordinary Income Forecast | ¥37.50B |
| Net Income Attributable to Owners Forecast | ¥27.50B |
| Basic EPS Forecast | ¥283.15 |
| Dividend Per Share Forecast | ¥55.00 |
| Property, Plant & Equipment | ¥251.65B | ¥222.70B | +¥28.95B |
| Intangible Assets | ¥56.10B | ¥11.66B | +¥44.44B |
| Goodwill | ¥42.17B | ¥2.42B | +¥39.75B |
| Investment Securities | ¥218.61B | ¥225.50B | ¥-6.90B |
| Total Assets | ¥865.83B | ¥865.67B | +¥165M |
| Current Liabilities | ¥175.69B | ¥197.72B | ¥-22.03B |
| Accounts Payable | ¥52.11B | ¥48.26B | +¥3.85B |
| Short-term Loans | ¥63.98B | ¥70.84B | ¥-6.85B |
| Non-current Liabilities | ¥266.00B | ¥255.94B | +¥10.07B |
| Long-term Loans | ¥152.51B | ¥155.65B | ¥-3.14B |
| Total Liabilities | ¥441.69B | ¥453.66B | ¥-11.96B |
| Total Equity | ¥424.14B | ¥412.01B | +¥12.13B |
| Capital Stock | ¥58.44B | ¥58.44B | ¥0 |
| Capital Surplus | ¥40.36B | ¥40.36B | ¥-3M |
| Retained Earnings | ¥266.46B | ¥260.91B | +¥5.54B |
| Treasury Stock | ¥-21.44B | ¥-21.49B | +¥46M |
| Owners' Equity | ¥406.69B | ¥395.08B | +¥11.61B |
| Working Capital | ¥115.07B | - | - |